STING1 and cancer: In agreement with the concept that TBK1 loss affects antitumor immunity, studies by the Cantley (140) and Barbie (133) groups have reported that immune evasion and metastatic behavior are associated with the cGAS/STING/TBK1 innate immune pathway in cancer cells (133, 140, 141).